118 related articles for article (PubMed ID: 25409424)
1. Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option.
Kindem S; Serra-Guillén C; Sorní G; Guillén C; Sanmartín O
JAMA Dermatol; 2015 Jan; 151(1):85-6. PubMed ID: 25409424
[No Abstract] [Full Text] [Related]
2. Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.
Anderson I; Routt ET; Jim On SC
Cutis; 2017 Mar; 99(3):E36-E39. PubMed ID: 28398427
[TBL] [Abstract][Full Text] [Related]
3. The hyperkeratotic variant of porokeratosis Mibelli is a distinct entity: clinical and ultrastructural evidence.
Schaller M; Korting HC; Kollmann M; Kind P
Dermatology; 1996; 192(3):255-8. PubMed ID: 8726642
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
[TBL] [Abstract][Full Text] [Related]
6. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
7. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
Bettencourt MS
J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of disseminated superficial actinic porokeratosis with calcipotriol.
Bakardzhiev I; Kavaklieva S; Pehlivanov G
Int J Dermatol; 2012 Sep; 51(9):1139-42. PubMed ID: 21726212
[No Abstract] [Full Text] [Related]
10. Ingenol mebutate gel for actinic keratosis.
Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
[TBL] [Abstract][Full Text] [Related]
11. Facial porokeratosis: A series of six patients.
Gutierrez EL; Galarza C; Ramos W; Tello M; De Paz PC; Bobbio L; Barquinero A; Ronceros G; Ortega-Loayza AG
Australas J Dermatol; 2010 Aug; 51(3):191-4. PubMed ID: 20695858
[TBL] [Abstract][Full Text] [Related]
12. [Porokeratosis Mibelli gigantea: case report and literature review].
Götz A; Kopera D; Wach F; Hohenleutner U; Landthaler M
Hautarzt; 1999 Jun; 50(6):435-8. PubMed ID: 10427514
[TBL] [Abstract][Full Text] [Related]
13. Treatment of disseminated superficial actinic porokeratosis with oral alitretinoin.
Park BJ; Oh EH; Kim JE; Ko JY; Ro YS
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):e505-e507. PubMed ID: 28543730
[No Abstract] [Full Text] [Related]
14. Disseminated porokeratosis of Mibelli: A case report.
Vij A; Doherty SD; LeLeux TM; Hsu S
Dermatol Online J; 2010 Dec; 16(12):12. PubMed ID: 21199638
[TBL] [Abstract][Full Text] [Related]
15. Disseminated superficial actinic porokeratosis of the scalp.
Naineni KK; Hohle R; Lucke T
Clin Exp Dermatol; 2007 Mar; 32(2):222-3. PubMed ID: 17137476
[No Abstract] [Full Text] [Related]
16. Porokeratosis of Mibelli and superficial disseminated porokeratosis.
Palleschi GM; Torchia D
J Cutan Pathol; 2008 Feb; 35(2):253-5. PubMed ID: 18190456
[No Abstract] [Full Text] [Related]
17. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
[TBL] [Abstract][Full Text] [Related]
18. Verrucous porokeratosis of Mibelli on the buttocks mimicking psoriasis.
Wallner JS; Fitzpatrick JE; Brice SL
Cutis; 2003 Nov; 72(5):391-3. PubMed ID: 14655780
[TBL] [Abstract][Full Text] [Related]
19. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
20. Porokeratosis of Mibelli: Involution and resolution with 5% imiquimod cream.
Gajic B; Tang K; Whitfeld M
Australas J Dermatol; 2011 Nov; 52(4):301-3. PubMed ID: 22070709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
